Literature DB >> 9557657

The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4.

P Thompson1, J Lu, G G Kaplan.   

Abstract

The hepatitis A virus cellular receptor 1 (HAVcr-1) cDNA codes for a class I integral membrane glycoprotein, termed havcr-1, of unknown natural function which serves as an African green monkey kidney (AGMK) cell receptor for HAV. The extracellular domain of havcr-1 has an N-terminal Cys-rich region that displays homology with sequences of members of the immunoglobulin superfamily, followed by a Thr/Ser/Pro (TSP)-rich region characteristic of mucin-like O-glycosylated proteins. The havcr-1 glycoprotein contains four putative N-glycosylation sites, two in the Cys-rich region and two in the TSP-rich region. To characterize havcr-1 and define region(s) involved in HAV receptor function, we expressed the TSP-rich region in Escherichia coli fused to glutathione S-transferase and generated antibodies (Ab) in rabbits (anti-GST2 Ab). Western blot analysis with anti-GST2 Ab detected 62- and 65-kDa bands in AGMK cells and 59-, 62-, and 65-kDa bands in dog cells transfected with the HAVcr-1 cDNA (cr5 cells) but not in dog cells transfected with the vector alone (DR2 cells). Treatment of AGMK and cr5 cell extracts with peptide-N-glycosidase F resulted in the collapse of the havcr-1-specific bands into a single band of 56 kDa, which indicated that different N-glycosylated forms of havcr-1 were expressed in these cells. Treatment of AGMK and cr5 cells with tunicamycin reduced binding of protective monoclonal Ab (MAb) 190/4, which suggested that N-glycans are required for binding of MAb 190/4 to havcr-1. To test this hypothesis, havcr-1 mutants lacking the N-glycosylation motif at the first site (mut1), second site (mut2), and both (mut3) sites were constructed and transfected into dog cells. Binding of MAb 190/4 and HAV to mut1 and mut3 cells was highly reduced, while binding to mut2 cells was not affected and binding to dog cells expressing an havcr-1 construct containing a deletion of the Cys-rich region (d1- cells) was undetectable. HAV-infected cr5 and mut2 cells but not mut1, mut3, d1-, and DR2 cells developed the characteristic cytoplasmic granular fluorescence of HAV-infected cells. These results indicate that the Cys-rich region of havcr-1 and its first N-glycosylation site are required for binding of protective MAb 190/4 and HAV receptor function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557657      PMCID: PMC109597          DOI: 10.1128/JVI.72.5.3751-3761.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Molecular cloning of the hepatitis A virus receptor from a simian cell line.

Authors:  M Ashida; C Hamada
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

2.  Identification of precursors of structural proteins VP1 and VP2 of hepatitis A virus.

Authors:  Y A Kazachkov; G K Dzagurov; G A Khozinskaya; M S Balayan; V Gauss-Müller
Journal:  J Med Virol       Date:  1992-07       Impact factor: 2.327

Review 3.  Why are proteins O-glycosylated?

Authors:  N Jentoft
Journal:  Trends Biochem Sci       Date:  1990-08       Impact factor: 13.807

4.  Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs.

Authors:  M Weitz; B M Baroudy; W L Maloy; J R Ticehurst; R H Purcell
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus.

Authors:  N E Bishop; D A Anderson
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

6.  Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region.

Authors:  X Y Jia; D F Summers; E Ehrenfeld
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

7.  Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture.

Authors:  J I Cohen; J R Ticehurst; S M Feinstone; B Rosenblum; R H Purcell
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

8.  Protection against hepatitis A by an inactivated vaccine.

Authors:  B L Innis; R Snitbhan; P Kunasol; T Laorakpongse; W Poopatanakool; C A Kozik; S Suntayakorn; T Suknuntapong; A Safary; D B Tang
Journal:  JAMA       Date:  1994-05-04       Impact factor: 56.272

9.  A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.

Authors:  A Werzberger; B Mensch; B Kuter; L Brown; J Lewis; R Sitrin; W Miller; D Shouval; B Wiens; G Calandra
Journal:  N Engl J Med       Date:  1992-08-13       Impact factor: 91.245

10.  Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.

Authors:  M Tesar; X Y Jia; D F Summers; E Ehrenfeld
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

View more
  18 in total

1.  Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1.

Authors:  E Silberstein; G Dveksler; G G Kaplan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions.

Authors:  Erica Silberstein; Li Xing; Willem van de Beek; Jinhua Lu; Holland Cheng; Gerardo G Kaplan
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

4.  Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice.

Authors:  Sheng Xiao; Craig R Brooks; Chen Zhu; Chuan Wu; Johanna M Sweere; Sonia Petecka; Ada Yeste; Francisco J Quintana; Takaharu Ichimura; Raymond A Sobel; Joseph V Bonventre; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

5.  Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions.

Authors:  Cecilia Tami; Erica Silberstein; Mohanraj Manangeeswaran; Gordon J Freeman; Sarah E Umetsu; Rosemarie H DeKruyff; Dale T Umetsu; Gerardo G Kaplan
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 6.  TIM-1 and TIM-3 proteins in immune regulation.

Authors:  Ee Wern Su; Jean Y Lin; Lawrence P Kane
Journal:  Cytokine       Date:  2008-08-15       Impact factor: 3.861

7.  Reply to Das et al., "TIM1 (HAVCR1): an Essential 'Receptor' or an 'Accessory Attachment Factor' for Hepatitis A Virus?"

Authors:  Maria Isabel Costafreda; Gerardo Kaplan
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

8.  Polymorphisms of the hepatitis A virus cellular receptor 1 in African green monkey kidney cells result in antigenic variants that do not react with protective monoclonal antibody 190/4.

Authors:  D Feigelstock; P Thompson; P Mattoo; G G Kaplan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 9.  TIM-1, a novel allergy and asthma susceptibility gene.

Authors:  Jennifer J McIntire; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

10.  The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture.

Authors:  Erica Silberstein; Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-10-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.